Official VapoCept® Distribution & Reference Desk Cycle 2026 US Climate Inventory Active · Direct Warehouse Allocation
Ingredients & Lab Assay Biological Mechanisms Supplement Facts & Label Direct Manufacturer Pricing Verified Buyer Reviews Frequently Asked Questions Usage Protocol & Dosage 60-Day Results Timeline Safety & Interactions Guide 60-Day Guarantee Decoded Batch & Lot Authenticity Portal Clinical Education Blog Claim Factory Stock · From $49
Official Packaging Ledger

Official VapoCept Supplement Facts: Label Transcript, Milligrams & Lab Assay

The verified VapoCept supplement facts panel decoded: exact disclosed active milligram amounts, full non-active ingredient disclosure, USP <2232> heavy metal testing records, and third-party Certificate of Analysis (CoA).

VapoCept Supplement Facts & Laboratory CoA Infographic Showcase
Figure 3.0: Official Supplement Facts Panel Transcript alongside Third-Party Analytical CoA Specifications. ISO 17025 Certified Assay

1. Full Regulatory Supplement Facts Transcription

Below is the exact transcript of the official FDA-compliant Supplement Facts panel printed on every container of VapoCept manufactured for the active 2026 production allocation cycle:

Supplement Facts
Serving Size: 1 Vegetable Capsule
Servings Per Container: 30
Amount Per Serving % Daily Value
Niacin (as nicotinic acid) 20 mg   125%
L-Citrulline 250 mg   *
L-Arginine 200 mg   *
Beta-Alanine 150 mg   *
Bacopa Monnieri Extract (whole herb; 20% bacosides) 100 mg   *
Huperzia Serrata Extract (aerial parts; 1% Huperzine A) 100 mcg   *
* Daily Value (DV) not established.
Percent Daily Values are based on a 2,000 calorie diet.
Other Ingredients: Vegetable Cellulose (capsule), Rice Flour, Vegetable Magnesium Stearate, Silicon Dioxide.
Allergen Declaration: Free from gluten, dairy, wheat, soy, eggs, tree nuts, peanuts, fish, crustacean shellfish, and artificial dyes.

2. Deciphering the Non-Active Excipients

Every dietary supplement in capsule form requires inert excipients to ensure the free flow of botanical powders into capsules during high-speed encapsulation machinery operations. VapoCept utilizes four clean, hypoallergenic non-active ingredients:

  • Vegetable Cellulose (Hypromellose): Derived from non-GMO plant pine pulp, this provides a 100% vegetarian, plant-based capsule shell that dissolves rapidly in gastric fluids within 10 to 15 minutes of ingestion.
  • Rice Flour: An inert, hypoallergenic botanical carrier used to standardize bulk volume and guarantee uniform distribution of micro-ingredients (such as Huperzia serrata) throughout every batch.
  • Vegetable Magnesium Stearate: A vegetable-sourced lubricant derived from palm oil that prevents fine botanical powders from adhering to steel encapsulation pins during compounding.
  • Silicon Dioxide: A naturally occurring mineral compound that acts as a desiccant and glidant, preventing moisture absorption and clumping inside the sealed container.

3. Third-Party Certificate of Analysis (CoA) Protocol

Prior to release for consumer distribution, every manufacturing lot of VapoCept undergoes third-party analytical laboratory verification. Testing is conducted by independent laboratories accredited under ISO/IEC 17025 standard operating procedures. The evaluation encompasses three critical testing categories:

Testing Category Analytical Technology Pharmacopeial Standard Observed Batch Specification Compliance Result
Heavy Metals (Pb, As, Cd, Hg) ICP-MS (Inductively Coupled Plasma) USP <2232> / Prop 65 All metals < 0.02 ppm PASS (100%)
Active Botanical Potency HPLC (High Performance Liquid Chromatography) Label Claim Verification 101.4% Bacoside / 100.8% Huperzine claim PASS (100%)
Microbiological Screening USP <2021> / <2022> Microbial Limits FDA Dietary Supplement cGMP Total plate count < 100 CFU/g; zero pathogens PASS (100%)
Physical Disintegration USP <2040> Disintegration Apparatus Gastric Release Benchmark Full capsule dissolution in < 14 minutes PASS (100%)

4. Manufacturing Facility cGMP Verification

VapoCept is compounded and packaged exclusively in US facilities that are formally registered with the United States Food and Drug Administration (FDA) and independently certified for Current Good Manufacturing Practices (cGMP) under 21 CFR Part 111. This manufacturing oversight ensures:

  • Complete Raw Material Traceability: Every botanical and amino acid lot is quarantined upon arrival and tested for botanical identity and purity before blending.
  • Climate-Controlled Cleanrooms: Compounding takes place in HEPA-filtered cleanrooms with continuous positive pressure, relative humidity regulation, and ambient temperature control.
  • Tamper-Evident Safety Packaging: Finished bottles receive induction-sealed inner safety barriers and heat-shrunk neck bands to prevent environmental moisture infiltration or tampering.

Frequently Asked Questions About the VapoCept Label

Q: Why does the label say 1 capsule daily instead of 2?
A: The formula was specifically compounded to deliver a complete 720.1 mg neurovascular active payload within a single size "0" vegetable capsule, maximizing user compliance and eliminating pill fatigue.

Q: Where do I find the expiration date on my bottle?
A: The production batch code (e.g. #VPC-2026-B48) and expiration date (typically 24 months from manufacture) are laser-etched directly onto the bottom of each amber bottle.

Q: Does VapoCept require refrigeration?
A: No. The vegetable capsules are stable at room temperature. Store your bottle tightly closed in a cool, dry pantry away from direct sunlight between 65°F and 72°F (18°C to 22°C).

5. Comprehensive Heavy Metals Toxicological Audit: USP <2232> Compliance

Dietary supplements derived from terrestrial botanicals naturally absorb trace minerals from agricultural soil. In low-quality products, heavy metals such as elemental lead, arsenic, cadmium, and mercury accumulate to toxic concentrations, causing sub-clinical neurotoxicity. To ensure uncompromising safety, VapoCept enforces compliance with United States Pharmacopeia (USP) General Chapter <2232> ("Elemental Contaminants in Dietary Supplements") and California Proposition 65 Maximum Allowable Dose Levels (MADL).

Testing is conducted using Inductively Coupled Plasma Mass Spectrometry (ICP-MS), an analytical method capable of detecting elemental impurities at parts-per-billion (ppb) concentrations. Below is the official analytical ledger for active batch #VPC-2026-B48:

Elemental Metal USP <2232> Permitted Daily Exposure (PDE) California Prop 65 Threshold Observed VapoCept Batch Value Safety Margin Factor
Inorganic Lead (Pb) < 5.0 μg/day < 0.5 μg/day < 0.02 μg/serving (PASS) 25x below Prop 65 limit
Inorganic Arsenic (As) < 15.0 μg/day < 10.0 μg/day < 0.01 μg/serving (PASS) 1,000x below USP limit
Cadmium (Cd) < 5.0 μg/day < 4.1 μg/day < 0.005 μg/serving (PASS) 820x below Prop 65 limit
Inorganic Mercury (Hg) < 15.0 μg/day < 3.0 μg/day < 0.002 μg/serving (PASS) 1,500x below Prop 65 limit

6. Microbiological Control & Pathogen Elimination Standards

Natural botanicals must also be screened rigorously for biological contaminants, molds, yeasts, and enterobacteria. Under USP <2021> and <2022> guidelines, finished containers are subjected to automated bio-luminescence and selective agar plating to ensure:

  • Total Aerobic Microbial Count (TAMC): Less than 100 CFU/gram (Permissible ceiling: 10,000 CFU/g).
  • Total Combined Yeast & Mold Count (TYMC): Less than 20 CFU/gram (Permissible ceiling: 1,000 CFU/g).
  • Escherichia coli & Salmonella species: Completely ABSENT in a 10-gram representative aliquot.
  • Staphylococcus aureus & Pseudomonas aeruginosa: Completely ABSENT in verified analytical cultures.

7. Capsule Shell Dissolution Kinetics (USP <2040>)

A high-potency nutritional formula is useless if the capsule shell fails to disintegrate in the upper gastrointestinal tract. Using a USP <2040> automated disintegration apparatus in simulated gastric fluid (0.1 N HCl at 37°C ± 0.5°C), VapoCept vegetable hypromellose capsules demonstrate a mean disintegration time of 11 minutes and 42 seconds. This rapid dissolution profile ensures prompt gastric release and optimal small intestinal absorption of amino acids and bacosides within the targeted morning window.

8. Stability Testing Under Accelerated and Real-Time Conditions

The chemical stability of botanical saponins and free-form amino acids is heavily influenced by ambient thermal exposure and relative humidity. In accordance with International Council for Harmonisation (ICH) Q1A(R2) stability guidelines, VapoCept undergoes both accelerated stability testing (40°C ± 2°C / 75% RH ± 5% RH for 6 months) and real-time room temperature testing (25°C ± 2°C / 60% RH ± 5% RH for 24 months).

Analytical HPLC chromatograms recorded at 3-month intervals confirm that total bacoside retention remains above 98.2% of label claim throughout the entire 24-month declared shelf life, with Huperzine A showing zero detectable degradation into inactive pyridine metabolites. The amber PET container barrier effectively filters out actinic ultraviolet radiation, preventing photo-oxidation of delicate amino acid residues.

9. Allergen Free Declaration & Cross-Contamination Safeguards

In strict compliance with the Food Allergen Labeling and Consumer Protection Act (FALCPA) and the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act, the VapoCept manufacturing facility enforces comprehensive allergen segregation protocols. The blending and encapsulation lines undergo complete mechanical swab testing using enzyme-linked immunosorbent assay (ELISA) kits capable of detecting food protein residues down to 2.5 parts per million (ppm).

VapoCept is formally certified free from:

  • Milk & Dairy Derivatives: Zero whey, casein, or lactose.
  • Eggs & Avian Derivatives: Zero egg albumin or lysozyme.
  • Peanuts & Tree Nuts: Zero almond, walnut, cashew, or peanut residues.
  • Wheat & Gluten: Tested < 5 ppm gluten (FDA threshold for gluten-free claim is < 20 ppm).
  • Soybeans & Soy Lecithin: Zero soy proteins or isoflavones.
  • Crustacean Shellfish & Fish: Zero marine-derived ingredients.
  • Sesame Seeds: Free from sesame proteins and oils.

10. Regulatory Compliance with DSHEA 1994 and FDA cGMP Directives

VapoCept operates in full compliance with Section 403(q) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) as amended by the Dietary Supplement Health and Education Act of 1994 (DSHEA). Label declarations strictly adhere to 21 CFR 101.36 ("Nutrition Labeling of Dietary Supplements"), with all quantitative active ingredient declarations verified through validated analytical laboratory methods. Raw materials undergo rigorous identity qualification, with Certificates of Analysis archived for a minimum of 5 years following batch manufacture to ensure complete traceability throughout the entire supply chain.

The production facility undergoes routine biennial inspections by state health departments and independent third-party audits (such as NSF International and UL Solutions) to confirm unwavering compliance with cGMP standards. These comprehensive measures ensure that every single amber container delivered to your home contains exactly the declared potency with zero adulterants or undeclared substances.